Patients Frequently Use Complementary, Alternative Medicines for Psoriasis When Other Therapies Fail

Many patients with psoriasis turn to complementary and alternative medicines (CAMs) when traditional therapies fail to treat their symptoms, according to a new study published by the Journal of the American Academy of Dermatology.
 
Despite the growing use of CAMs for psoriasis, many patients may misunderstand the benefits of these medicines, according to the study. The authors noted that prior research shows that up to 62% of patients reported using CAM for their psoriasis symptoms. For the current study, the authors examined the types of CAMs used and the patients’ reasons for using them.
 
Through a survey distributed by the National Psoriasis Foundation, 219 patients with psoriasis participated in the study by answering questions about CAM use. Overall, 41% reported using alternative therapies, with higher utilization found in patients who consider their psoriasis to be severe than among those who do not, according to the study. Additionally, 39.5% reported using complementary therapies, with women more likely to report use than men.
 
The study showed that the most common reasons for using CAMs were that traditional medications did not help or had adverse effects. Only 4% reported care access as a reason. A total of 42.6% said they would recommend CAMs to others.
 
Although patients may resort to using CAMs when the treatment they were initially prescribed did not work for them, they still may not completely understand which products to use, the researchers noted.
 
Many of the CAMs that patients reported using have not exhibited efficacy or have not been studied per a recent systematic review. Although vitamins were the most frequently reported therapy, neither vitamin D nor B12 have documented efficacy. Indigo naturalis, a plant extract recognized for use in inflammatory conditions, has demonstrated efficacy but was not reported by any patients in the survey. However, Dead Sea treatments, which have shown therapeutic benefit as well, were commonly reported.
 
Knowing that CAM use is frequent among this patient population, providers can include discussions on more evidence-based CAMs to help patients choose products that may be more beneficial than those supported by limited evidence. 
 
Reference
 
Friedman AJ, Murphy EC, Nussbaum D, et al. Use of complementary and alternative medicine by patients with psoriasis. Journal of the American Academy of Dermatology. 2019. Doi: https://doi.org/10.1016/j.jaad.2019.03.059
 
 



Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Related Articles

As young patients with bone cancer are often treated with high doses of chemotherapy before and after surgery, researchers wanted to develop gentler treatment options.
Midazolam (Nayzilam) is indicated for seizures that are distinct from a patient's usual seizure pattern, in individuals age 12 years and older with epilepsy.
The study focused on the comparative risk of infection across 7 systemic biologics.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$